Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism RIPK1 inhibitors(Receptor-interacting serine/threonine-protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cerebrovascular Disorders | Discovery | - | 15 Jan 2026 | |
| Endocrinology and Metabolic Disease | Discovery | - | 15 Jan 2026 | |
| Eye Diseases | Discovery | - | 15 Jan 2026 | |
| Neurodegenerative Diseases | Discovery | - | 15 Jan 2026 | |
| Other Diseases | Discovery | - | 15 Jan 2026 | |
| Pancreatitis | Discovery | - | 15 Jan 2026 |





